Physician profile
Corey D Berlin
NPI 1154399418
$741,737.63
in general payments reported to CMS, 2019-2025
72 companies · $56K in 2025
The $56K reported for 2025 was more than what 96% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212K · 2020: $63K · 2021: $80K · 2022: $166K · 2023: $92K · 2024: $74K · 2025: $56K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $169K · Travel and Lodging: $32K · Food and Beverage: $15K · Honoraria: $5,006 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $168,957.50 |
| Travel and Lodging | $31,984.01 |
| Food and Beverage | $15,486.99 |
| Honoraria | $5,006.25 |
| Education | $107.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $270,967.74 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $221,596.14 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72,239.13 | 2019-2025 | Jardiance, Synjardy, Trijardy Xr |
| Amarin Pharma, INC. | $49,899.70 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $35,834.96 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $33,194.21 | 2019-2023 | Farxiga |
| Sanofi-Aventis U.S. LLC | $15,481.36 | 2019-2025 | |
| Mannkind Corporation | $8,487.07 | 2019-2025 | Afrezza |
| Radius Health, INC. | $6,921.76 | 2019-2025 | Tymlos |
| Xeris Pharmaceuticals, INC. | $5,721.51 | 2020-2025 | Recorlev, Gvoke Hypopen |
| Corcept Therapeutics | $3,395.24 | 2019-2025 | Korlym |
| Zealand Pharma US, INC. | $3,013.98 | 2021-2022 | |
| Abbott Laboratories | $2,383.41 | 2019-2025 | Freestyle Libre 3, Proclaim |
| Esperion Therapeutics, INC. | $1,607.47 | 2020-2025 | Nexletol |
| Amgen INC. | $1,436.21 | 2019-2025 | Tepezza, Evenity, Prolia |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $947.38 | 2019-2025 | Dexcom G6 Transmitter |
| Insulet Corporation | $910.61 | 2019-2025 | Omnipod |
| Ibsa Pharma INC. | $806.11 | 2020-2025 | Tirosint, Licart, Licart |
| Abbvie INC. | $748.43 | 2019-2025 | Synthroid |
| Antares Pharma, INC. | $595.50 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Medtronic Minimed, INC. | $507.92 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $488.16 | 2021-2025 | |
| Cequr Corporation | $389.16 | 2022-2025 | Cequr Simplicity |
| Horizon Therapeutics Plc | $372.68 | 2021-2023 | Tepezza |
| Medtronic, INC. | $367.10 | 2021-2025 | Minimed 780g, Inceptiv, Intellis Adaptivestim |
| Beta Bionics, INC. | $349.42 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Kowa Pharmaceuticals America, INC. | $277.11 | 2019-2022 | |
| Tolmar, INC. | $174.16 | 2025 | Jatenzo |
| Novartis Pharmaceuticals Corporation | $171.30 | 2022-2025 | |
| Almatica Pharma LLC | $167.65 | 2024-2025 | Teriparatide, Loreev Xr |
| Merck Sharp & Dohme LLC | $164.05 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $156.92 | 2022-2025 | Unithroid |
| Tandem Diabetes Care, INC. | $141.35 | 2019-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Recordati_rare_diseases_inc. | $115.69 | 2022-2025 | Isturisa, Signifor Lar |
| Ascendis Pharma Endocrinology INC | $110.63 | 2023-2025 | Yorvipath |
| Idorsia Pharmaceuticals US INC | $109.38 | 2023 | Quviviq |
| Lifescan, INC. | $106.86 | 2020-2022 | |
| Nestle Healthcare Nutrition INC. | $98.84 | 2020-2022 | |
| Astellas Pharma US INC | $98.67 | 2023-2025 | Veozah, Myrbetriq |
| Senseonics, Incorporated | $88.00 | 2019 | |
| Amphastar Pharmaceuticals, INC. | $76.72 | 2024-2025 | |
| Pfizer INC. | $67.61 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $64.70 | 2019-2020 | |
| Boston Scientific Corporation | $64.22 | 2022 | |
| Shire North American Group INC | $59.97 | 2019 | |
| Nevro Corp. | $56.83 | 2021-2024 | Senza |
| Clarus Therapeutics INC. | $55.75 | 2021 | |
| Verity Pharmaceuticals INC. | $54.49 | 2025 | Tlando |
| Halozyme INC | $41.80 | 2023 | |
| Alexion Pharmaceuticals, INC. | $41.60 | 2024-2025 | Strensiq |
| Kyowa Kirin, INC. | $40.61 | 2023-2024 | Crysvita |
| Rhythm Pharmaceuticals, INC. | $36.62 | 2025 | Imcivree |
| Eusa Pharma (US) LLC | $35.78 | 2022 | |
| Gilead Sciences, INC. | $31.47 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $30.92 | 2020-2023 | Crysvita |
| Intra-Sana Laboratories | $30.64 | 2024-2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Acella Pharmaceuticals, LLC | $28.73 | 2019-2020 | |
| Aimmune Therapeutics, INC. | $26.29 | 2025 | Zenpep |
| Chiesi USA, INC. | $25.17 | 2025 | Mycapssa |
| Takeda Pharmaceuticals U.S.A., INC. | $24.55 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $20.99 | 2021 | |
| Companion Medical, INC. | $19.66 | 2019 | |
| Embecta Corp. | $19.58 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Grt US Holding, INC. | $19.11 | 2022 | |
| Vivus LLC | $16.90 | 2025 | Qsymia |
| Amryt Pharma Holdings LTD | $16.32 | 2022 | |
| Acerus Pharmaceuticals Corporation | $15.71 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $15.39 | 2019 | |
| Currax Pharmaceuticals LLC | $15.10 | 2022 | |
| Endo USA, INC. | $14.47 | 2024 | Aveed |
| Azurity Pharmaceuticals, INC. | $13.97 | 2023 | Adthyza |
| Ipsen Biopharmaceuticals, INC | $12.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Berlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.